Kaleo Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
220
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
7
Kaleo General Information
Description
Manufacturer of pharmaceutical products intended to empower patients and families to live fuller, bolder lives. The company's products use drug delivery technology and offer epinephrine auto-injectors and focus on delivery molecules, biologics, biosimilars, human factors engineering, and vaccines, enabling doctors to confidently take control in potentially life-threatening situations.
Contact Information
Website
www.kaleo.comCorporate Office
- 111 Virginia Street
- Suite 300
- Richmond, VA 23219
- United States
Corporate Office
- 111 Virginia Street
- Suite 300
- Richmond, VA 23219
- United States
Kaleo Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kaleo Comparisons
Industry
Financing
Details
Kaleo Competitors (2)
One of Kaleo’s 2 competitors is Stallergenes Greer, a Private Equity-Backed company based in Baar, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Stallergenes Greer | Private Equity-Backed | Baar, Switzerland | ||||
| Adamis Pharmaceuticals | Corporation | San Diego, CA |
Kaleo Patents
Kaleo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1141123-S1 | Retention structure for medicament delivery device | Active | 25-Oct-2024 | ||
| WO-2026006286-A1 | Devices and methods for delivering medicaments | Pending | 25-Jun-2024 | ||
| WO-2024263566-A2 | Dry powder compositions for rapid reconstitution and parenteral delivery | Inactive | 20-Jun-2023 | ||
| WO-2024263566-A3 | Dry powder compositions for rapid reconstitution and parenteral delivery | Inactive | 20-Jun-2023 | ||
| US-20260315685-A1 | Devices and methods for delivering reconstituted medicaments | Pending | 22-May-2023 | A61M5/1409 |
Kaleo Signals
Kaleo Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kaleo FAQs
-
When was Kaleo founded?
Kaleo was founded in 2004.
-
Where is Kaleo headquartered?
Kaleo is headquartered in Richmond, VA.
-
What is the size of Kaleo?
Kaleo has 220 total employees.
-
What industry is Kaleo in?
Kaleo’s primary industry is Drug Delivery.
-
Is Kaleo a private or public company?
Kaleo is a Private company.
-
What is the current valuation of Kaleo?
The current valuation of Kaleo is .
-
What is Kaleo’s current revenue?
The current revenue for Kaleo is .
-
How much funding has Kaleo raised over time?
Kaleo has raised $195M.
-
Who are Kaleo’s investors?
CVC Marathon and Princeton Biopharma Capital Partners have invested in Kaleo.
-
Who are Kaleo’s competitors?
Stallergenes Greer and Adamis Pharmaceuticals are competitors of Kaleo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process